Stonepine Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100,000
Closed -$415K 75
2025
Q2
$415K Buy
+100,000
New +$626K 0.41% 44

Other funds holding VSTM

Stonepine Capital Management's VSTM Position: Q1 2026 in Review

Stonepine Capital Management increased its Verastem (VSTM) stake by 21% in Q1 2026, buying an estimated $3.52M and bringing the position to 3,302,300 shares worth $17.5M. The position accounts for 7.01% of the portfolio, ranked #3.

Stonepine Capital Management first reported a position in VSTM in Q4 2017 and has held it in 9 quarters since. The position peaked at $23.6M in Q3 2025. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • Stonepine Capital Management held 3,302,300 shares of Verastem worth $17.5M as of Q1 2026.
  • Stonepine Capital Management bought 570,221 Verastem shares in Q1 2026, an estimated $3.52M.
  • Verastem made up 7.01% of Stonepine Capital Management's portfolio in Q1 2026, its #3 holding.
  • Stonepine Capital Management first reported a position in Verastem in Q4 2017 and has held it in 9 quarters since.
  • Stonepine Capital Management's Verastem position peaked at $23.6M in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.